Lupin LimitedNSE: LUPIN

Press Release Nov 17 2023

· Issued by Lupin Limited

Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated November 17, 2023, titled "Lupin Receives Approval from U.S. FDA for Ganirelix Acetate Injection.".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases